Overview

Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to investigate the safety and effectiveness of application of intravitreal conbercept injection as the primary treatment for exudative circumscribed choroidal haemangioma.
Phase:
Early Phase 1
Details
Lead Sponsor:
Sun Yat-sen University